Search & Filter

(Washington, D.C.): Last week, Americans United for Life (AUL) signed on to the amicus brief led by Advancing American Freedom in Louisiana v. FDA, which continues to be litigated following the Supreme Court’s decision to reverse the Fifth Circuit’s stay on mail-order abortion regulations last month. Our joint briefing argues that states, including Louisiana, have the authority to regulate […] The post Americans United for Life Joins Advancing American Freedom on Amicus Brief in Louisiana v. FDA appeared first on Americans United for Life .

(Washington, D.C.): The U.S. Court of Appeals for the Fifth Circuit has granted a motion to stay the Food and Drug Administration’s (FDA) 2023 Risk Evaluation and Mitigation Strategy (REMS) for mifepristone, which established mail-order access to the abortion drug beginning under the Biden Administration. This stay was granted upon appeal by the plaintiffs, including the State of Louisiana, after the U.S. District Court the Western District of Louisiana granted […] The post Fifth Circuit Grants Stay in Louisiana v. FDA, Blocking Mail-Order Abortion appeared first on Americans United for Life .

(Washington, D.C.): Earlier today, the Department of Justice under the Trump Administration requested a federal court to pause the case in Louisiana v. FDA and deny the client immediate relief pending the Food and Drug Administration (FDA) review of the abortion pill, mifepristone. There is no public evidence that this review is actively being conducted. Sarah Zagorski, Senior Director of Public Relations & Communications for Americans United for Life […] The post Trump DOJ Asks for Delay in Essential Abortion Pill Case, Pending FDA Review with No Deadline appeared first on Americans United fo